|
|
|
Insider
Information: |
Landry Robert E |
Relationship: |
EVP Finance CFO |
City: |
Tarrytown |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
23,693 |
|
Indirect Shares
|
270 |
|
|
Direct
Value |
$23,733,989 |
|
|
Indirect Value
|
$270,467 |
|
|
Total
Shares |
23,963 |
|
|
Total
Value |
$24,004,456 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
Percentage
Gain/Loss : |
0.0%
|
16.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Regeneron Pharmaceuticals Inc |
REGN |
EVP Finance CFO |
2024-02-02 |
23,693 |
2024-02-02 |
270 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
158 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
REGN |
Regeneron Pharmaceuticals... |
SVP Fin, Dep CFO |
|
2013-09-09 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
|
2018-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
17,348 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
|
2019-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
7,625 |
24,973 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
|
2020-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,930 |
25,903 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
|
2021-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,971 |
29,957 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
|
2022-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,853 |
32,844 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
|
2017-08-08 |
4 |
AS |
$469.91 |
$248,372 |
D/D |
(526) |
7,099 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
|
2017-08-23 |
4 |
AS |
$474.14 |
$222,981 |
D/D |
(468) |
7,099 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
|
2017-08-31 |
4 |
AS |
$487.88 |
$210,693 |
D/D |
(427) |
7,099 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
|
2017-09-05 |
4 |
AS |
$500.33 |
$94,700 |
D/D |
(189) |
7,573 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
|
2017-09-06 |
4 |
AS |
$496.51 |
$235,873 |
D/D |
(474) |
7,099 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
|
2020-02-13 |
4 |
AS |
$398.63 |
$42,806 |
D/D |
(107) |
24,973 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
|
2020-02-25 |
4 |
AS |
$438.00 |
$96,088 |
D/D |
(214) |
25,173 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
|
2020-02-26 |
4 |
AS |
$452.04 |
$91,242 |
D/D |
(200) |
24,973 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
|
2020-04-01 |
4 |
AS |
$478.97 |
$292,811 |
D/D |
(600) |
24,373 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
|
2020-04-02 |
4 |
AS |
$495.24 |
$52,068 |
D/D |
(105) |
25,056 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
|
2020-04-02 |
4 |
AS |
$483.51 |
$610,672 |
D/D |
(1,248) |
25,161 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
|
2020-04-03 |
4 |
AS |
$489.50 |
$337,592 |
D/D |
(683) |
24,373 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
|
2020-04-07 |
4 |
AS |
$497.50 |
$346,271 |
D/D |
(696) |
24,373 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
|
2020-04-13 |
4 |
AS |
$505.60 |
$422,108 |
D/D |
(828) |
24,373 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
|
2020-04-15 |
4 |
AS |
$516.89 |
$442,276 |
D/D |
(853) |
24,373 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
|
2020-04-17 |
4 |
AS |
$540.70 |
$552,661 |
D/D |
(991) |
24,373 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
|
2020-04-20 |
4 |
AS |
$562.71 |
$1,842,539 |
D/D |
(3,250) |
24,373 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
|
2020-06-09 |
4 |
AS |
$602.38 |
$2,596,792 |
D/D |
(4,271) |
24,373 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
|
2020-06-11 |
4 |
AS |
$607.50 |
$604,731 |
D/D |
(988) |
24,373 |
0 |
% |
|
158 Records found
|
|
Page 1 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|